indices
发表于 2025-3-23 10:23:50
Sheikh Rayees,Inshah Din,Fayaz A MalikGives a complete knowledge of the different lung diseases.Discusses the pathophysiology of the specific diseases in a detailed manner.Provides in depth details of current treatments and future perspec
开花期女
发表于 2025-3-23 13:53:09
http://reply.papertrans.cn/23/2264/226389/226389_12.png
esoteric
发表于 2025-3-23 18:33:30
es in depth details of current treatments and future perspecChronic lung diseases: pathophysiology and therapeutics provides a much-needed reference tool for pathologists, practicing pulmonologists and researchers who are currently working on lung related diseases. Each chapter addresses a specific
发怨言
发表于 2025-3-24 01:29:19
Book 2020, lung cancer, tuberculosis, chronic pneumonia, acute respiratory distress syndrome, asthma, cystic fibrosis and pulmonary hypertension. Medical students and researchers whose work involves pulmonary related disorders will find this work both instructive and informative..
放大
发表于 2025-3-24 04:55:28
http://reply.papertrans.cn/23/2264/226389/226389_15.png
使乳化
发表于 2025-3-24 09:28:20
https://doi.org/10.1007/978-3-031-62941-9y of eosinophilic illness progression. Close follow-up is important given the difficulty in weaning patients from glucocorticoids with many patients developing sequelae of chronic glucocorticoid therapy. Hence, searching for various treatments is being prioritized by the scientific community.
净礼
发表于 2025-3-24 12:19:22
https://doi.org/10.1007/978-3-031-62941-9along with the involvement of cells and transcriptional factors, current treatment regimen with its drawbacks, and future treatment options. This chapter represents an up-to-date overview of these disease conditions and its therapy in global perspectives.
Servile
发表于 2025-3-24 17:47:34
http://reply.papertrans.cn/23/2264/226389/226389_18.png
Frequency
发表于 2025-3-24 19:30:58
http://reply.papertrans.cn/23/2264/226389/226389_19.png
蜡烛
发表于 2025-3-24 23:43:21
Therapeutic Advances in the Management of Pulmonary Arterial Hypertension,mortality, and a median survival of only 5–7 years. Clinically, PAH is defined as mean pulmonary arterial pressure >20 mmHg at rest with normal left atrial pressure. PAH is characterized by remodeling of the pulmonary vasculature due to pulmonary vascular endothelial and smooth cell proliferation. T